|drug8||0.12% Chlorhexidine Gluconate Mouth Rinse Wiki||1.00|
|drug10||0.5% Povidone Iodine Wiki||1.00|
|drug13||0.9% Normal Saline Wiki||1.00|
|D041881||Cholecystitis, Acute NIH||1.00|
There is one clinical trial.
Researchers know that the virus that causes COVID-19 has been found in the saliva (spit) of individuals who exhibit signs of the disease. Investigators would like to test the ability of three mouthwashes to reduce the levels of this virus in participants' mouths. Investigators will ask participants to use a liquid to swish around in the mouth for 30 seconds and spit it into a collection cup. Investigators will also collect spit from participants before and after participants use the mouthwash. Although participants will have no direct benefits from the study, investigators will gain a wealth of information that would benefit patients who are at risk for COVID-19.
Description: Saliva load was expressed in copies x 10 8 of COVID-19 RNAMeasure: real time reverse transcriptase quantitative PCR Time: 3 measurements of changes from times 0 minutes. vs:15 minutes, and vs: 45 minutes during a single session
Description: cycle thresholdsMeasure: ct values Time: 3 measurements of changes from times 0 minutes.vs:15 minutes, and vs:45 minutes during a single session
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports